Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Gastric Cancer

Free Subscription Articles published in Int J Oncol Retrieve available abstracts of 62 articles: HTML format Text format

Single Articles

March 2019
1. ZHI X, Li B, Li Z, Zhang J, et al
   Adrenergic modulation of AMPKdependent autophagy by chronic stress enhances cell proliferation and survival in gastric cancer.
   Int J Oncol. 2019 Mar 18. doi: 10.3892/ijo.2019.4753.
   PubMed     Text format     Abstract available
   
   
   
2. CHEN C, Tang X, Liu Y, Zhu J, et al
   Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review).
   Int J Oncol. 2019 Mar 18. doi: 10.3892/ijo.2019.4751.
   PubMed     Text format     Abstract available
   
   
   
3. FU R, Wang X, Hu Y, Du H, et al
   Solamargine inhibits gastric cancer progression by regulating the expression of lncNEAT1_2 via the MAPK signaling pathway.
   Int J Oncol. 2019 Mar 12. doi: 10.3892/ijo.2019.4744.
   PubMed     Text format     Abstract available
   
   
   February 2019
4. LI J, Feng D, Gao C, Zhang Y, et al
   Isoforms S and L of MRPL33 from alternative splicing have isoformspecific roles in the chemoresponse to epirubicin in gastric cancer cells via the PI3K/AKT signaling pathway.
   Int J Oncol. 2019 Feb 27. doi: 10.3892/ijo.2019.4728.
   PubMed     Text format     Abstract available
   
   
   
5. AN C, Li H, Zhang X, Wang J, et al
   Silencing of COPB2 inhibits the proliferation of gastric cancer cells and induces apoptosis via suppression of the RTK signaling pathway.
   Int J Oncol. 2019 Feb 18. doi: 10.3892/ijo.2019.4717.
   PubMed     Text format     Abstract available
   
   
   January 2019
6. WANG S, Yao Y, Rao C, Zheng G, et al
   25-HC decreases the sensitivity of human gastric cancer cells to 5-fluorouracil and promotes cells invasion via the TLR2/NF-kappaB signaling pathway.
   Int J Oncol. 2019 Jan 11. doi: 10.3892/ijo.2019.4684.
   PubMed     Text format     Abstract available
   
   
   
7. JIAO Y, Yang H, Qian J, Gong Y, et al
   miR36645P suppresses the proliferation and metastasis of gastric cancer by attenuating the NFkappaB signaling pathway through targeting MTDH.
   Int J Oncol. 2019 Jan 8. doi: 10.3892/ijo.2019.4680.
   PubMed     Text format     Abstract available
   
   
   
8. SHU F, Zou X, Tuo H, She S, et al
   Stathmin gene silencing suppresses proliferation, migration and invasion of gastric cancer cells via AKT/sCLU and STAT3 signaling.
   Int J Oncol. 2019 Jan 3. doi: 10.3892/ijo.2019.4674.
   PubMed     Text format     Abstract available
   
   
   December 2018
9. HUANG L, Wang ZY, Pan DD
   Penicillinbinding protein 1A mutationpositive Helicobacter pylori promotes epithelialmesenchymal transition in gastric cancer via the suppression of microRNA134.
   Int J Oncol. 2018 Dec 12. doi: 10.3892/ijo.2018.4665.
   PubMed     Text format     Abstract available
   
   
   November 2018
10. MA C, Xie J, Luo C, Yin H, et al
    OxLDL promotes lymphangiogenesis and lymphatic metastasis in gastric cancer by upregulating VEGFC expression and secretion.
    Int J Oncol. 2018 Nov 26. doi: 10.3892/ijo.2018.4648.
    PubMed     Text format     Abstract available
    
    
    
11. FANG Z, Zhong M, Wang Y, Yuan X, et al
    miR381 and miR489 suppress cell proliferation and invasion by targeting CUL4B via the Wnt/betacatenin pathway in gastric cancer.
    Int J Oncol. 2018 Nov 26. doi: 10.3892/ijo.2018.4646.
    PubMed     Text format     Abstract available
    
    
    
12. SONG Y, Wang R, Li LW, Liu X, et al
    Long non-coding RNA HOTAIR mediates the switching of histone H3 lysine 27 acetylation to methylation to promote epithelial-to-mesenchymal transition in gastric cancer.
    Int J Oncol. 2018 Nov 5. doi: 10.3892/ijo.2018.4625.
    PubMed     Text format     Abstract available
    
    
    
13. LIU F, Cheng L, Xu J, Guo F, et al
    miR-17-92 functions as an oncogene and modulates NF-kappaB signaling by targeting TRAF3 in MGC-803 human gastric cancer cells.
    Int J Oncol. 2018;53:2241-2257.
    PubMed     Text format     Abstract available
    
    
    
14. NGABIRE D, Seong YA, Patil MP, Niyonizigiye I, et al
    Induction of apoptosis and G1 phase cell cycle arrest by Aster incisus in AGS gastric adenocarcinoma cells.
    Int J Oncol. 2018;53:2300-2308.
    PubMed     Text format     Abstract available
    
    
    October 2018
15. YAN L, Zhang J, Guo D, Ma J, et al
    IL-21R functions as an oncogenic factor and is regulated by the lncRNA MALAT1/miR-125a-3p axis in gastric cancer.
    Int J Oncol. 2018 Oct 31. doi: 10.3892/ijo.2018.4612.
    PubMed     Text format     Abstract available
    
    
    
16. XI Z, Si J, Nan J
    LncRNA MALAT1 potentiates autophagyassociated cisplatin resistance by regulating the microRNA30b/autophagyrelated gene 5 axis in gastric cancer.
    Int J Oncol. 2018 Oct 26. doi: 10.3892/ijo.2018.4609.
    PubMed     Text format     Abstract available
    
    
    
17. WANG M, Qiu R, Yu S, Xu X, et al
    Paclitaxelresistant gastric cancer MGC803 cells promote epithelialtomesenchymal transition and chemoresistance in paclitaxelsensitive cells via exosomal delivery of miR1555p.
    Int J Oncol. 2018 Oct 22. doi: 10.3892/ijo.2018.4601.
    PubMed     Text format     Abstract available
    
    
    
18. YAN R, Li K, Yuan DW, Wang HN, et al
    Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
    Int J Oncol. 2018 Oct 12. doi: 10.3892/ijo.2018.4595.
    PubMed     Text format     Abstract available
    
    
    
19. HUANG H, Tang J, Zhang L, Bu Y, et al
    miR-874 regulates multiple-drug resistance in gastric cancer by targeting ATG16L1.
    Int J Oncol. 2018 Oct 11. doi: 10.3892/ijo.2018.4593.
    PubMed     Text format     Abstract available
    
    
    September 2018
20. CHUA PJ, Lim JP, Guo TT, Khanna P, et al
    Y-box binding protein-1 and STAT3 independently regulate ATP-binding cassette transporters in the chemoresistance of gastric cancer cells.
    Int J Oncol. 2018 Sep 11. doi: 10.3892/ijo.2018.4557.
    PubMed     Text format     Abstract available
    
    
    August 2018
21. CAO B, Zhao Y, Zhang Z, Li H, et al
    Gene regulatory network construction identified NFYA as a diffuse subtype-specific prognostic factor in gastric cancer.
    Int J Oncol. 2018 Aug 9. doi: 10.3892/ijo.2018.4519.
    PubMed     Text format     Abstract available
    
    
    June 2018
22. LI L, Cui Y, Ye L, Zhao Z, et al
    Psoriasin overexpression confers drug resistance to cisplatin by activating ERK in gastric cancer.
    Int J Oncol. 2018 Jun 26. doi: 10.3892/ijo.2018.4455.
    PubMed     Text format     Abstract available
    
    
    
23. PEI L, He X, Li S, Sun R, et al
    KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
    Int J Oncol. 2018 Jun 19. doi: 10.3892/ijo.2018.4446.
    PubMed     Text format     Abstract available
    
    
    
24. HU C, Zhou Y, Liu C, Kang Y, et al
    A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
    Int J Oncol. 2018 Jun 6. doi: 10.3892/ijo.2018.4433.
    PubMed     Text format     Abstract available
    
    
    May 2018
25. OKUGAWA Y, Toiyama Y, Ichikawa T, Kawamura M, et al
    Colony-stimulating factor-1 and colony-stimulating factor-1 receptor co-expression is associated with disease progression in gastric cancer.
    Int J Oncol. 2018 May 16. doi: 10.3892/ijo.2018.4406.
    PubMed     Text format     Abstract available
    
    
    April 2018
26. WANG J, Liang WJ, Min GT, Wang HP, et al
    LTBP2 promotes the migration and invasion of gastric cancer cells and predicts poor outcome of patients with gastric cancer.
    Int J Oncol. 2018 Apr 4. doi: 10.3892/ijo.2018.4356.
    PubMed     Text format     Abstract available
    
    
    March 2018
27. YU S, Li L, Wu Q, Dou N, et al
    PPP2R2D, a regulatory subunit of protein phosphatase 2A, promotes gastric cancer growth and metastasis via mechanistic target of rapamycin activation.
    Int J Oncol. 2018 Mar 20. doi: 10.3892/ijo.2018.4329.
    PubMed     Text format     Abstract available
    
    
    February 2018
28. ZHOU D, Zhou Y, Li C, Yang L, et al
    Silencing of B7-H4 suppresses the tumorigenicity of the MGC-803 human gastric cancer cell line and promotes cell apoptosis via the mitochondrial signaling pathway.
    Int J Oncol. 2018 Feb 13. doi: 10.3892/ijo.2018.4274.
    PubMed     Text format     Abstract available
    
    
    
29. LU M, Huang Y, Sun W, Li P, et al
    miR-135b-5p promotes gastric cancer progression by targeting CMTM3.
    Int J Oncol. 2018;52:589-598.
    PubMed     Text format     Abstract available
    
    
    
30. LI L, Yang D, Cui D, Li Y, et al
    Quantitative proteomics analysis of the role of tetraspanin-8 in the drug resistance of gastric cancer.
    Int J Oncol. 2018;52:473-484.
    PubMed     Text format     Abstract available
    
    
    January 2018
31. LIAN G, Li L, Shi Y, Jing C, et al
    BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells.
    Int J Oncol. 2018 Jan 25. doi: 10.3892/ijo.2018.4255.
    PubMed     Text format     Abstract available
    
    
    
32. FEI HJ, Chen SC, Zhang JY, Li SY, et al
    Identification of significant biomarkers and pathways associated with gastric carcinogenesis by whole genome-wide expression profiling analysis.
    Int J Oncol. 2018 Jan 11. doi: 10.3892/ijo.2018.4243.
    PubMed     Text format     Abstract available
    
    
    
33. ARAI H, Wada R, Ishino K, Kudo M, et al
    Expression of DNA damage response proteins in gastric cancer: Comprehensive protein profiling and histological analysis.
    Int J Oncol. 2018 Jan 5. doi: 10.3892/ijo.2018.4238.
    PubMed     Text format     Abstract available
    
    
    December 2017
34. YAN H, Xiao F, Zou J, Qiu C, et al
    NR4A1-induced increase in the sensitivity of a human gastric cancer line to TNFalpha-mediated apoptosis is associated with the inhibition of JNK/Parkin-dependent mitophagy.
    Int J Oncol. 2017 Dec 4. doi: 10.3892/ijo.2017.4216.
    PubMed     Text format     Abstract available
    
    
    October 2017
35. WANG YM, Gu ML, Meng FS, Jiao WR, et al
    Histone acetyltransferase p300/CBP inhibitor C646 blocks the survival and invasion pathways of gastric cancer cell lines.
    Int J Oncol. 2017 Oct 23. doi: 10.3892/ijo.2017.4176.
    PubMed     Text format     Abstract available
    
    
    
36. LIU Y, Zhang C, Zhao L, Du N, et al
    APPL1 promotes the migration of gastric cancer cells by regulating Akt2 phosphorylation.
    Int J Oncol. 2017;51:1343-1351.
    PubMed     Text format     Abstract available
    
    
    
37. ZHOU J, Wu X, Li G, Gao X, et al
    Prediction of radiosensitive patients with gastric cancer by developing gene signature.
    Int J Oncol. 2017;51:1067-1076.
    PubMed     Text format     Abstract available
    
    
    September 2017
38. WANG G, Huang YX, Zhang R, Hou LD, et al
    Toosendanin suppresses oncogenic phenotypes of human gastric carcinoma SGC7901 cells partly via miR200amediated downregulation of beta-catenin pathway.
    Int J Oncol. 2017 Sep 27. doi: 10.3892/ijo.2017.4139.
    PubMed     Text format     Abstract available
    
    
    
39. WEI F, Jiang X, Gao HY, Gao SH, et al
    Liquiritin induces apoptosis and autophagy in cisplatin (DDP)-resistant gastric cancer cells in vitro and xenograft nude mice in vivo.
    Int J Oncol. 2017 Sep 22. doi: 10.3892/ijo.2017.4134.
    PubMed     Text format     Abstract available
    
    
    August 2017
40. PAN Z, Tian Y, Zhang B, Zhang X, et al
    YAP signaling in gastric cancer-derived mesenchymal stem cells is critical for its promoting role in cancer progression.
    Int J Oncol. 2017 Aug 23. doi: 10.3892/ijo.2017.4101.
    PubMed     Text format     Abstract available
    
    
    July 2017
41. LEE H, Saini N, Parris AB, Zhao M, et al
    Ganetespib induces G2/M cell cycle arrest and apoptosis in gastric cancer cells through targeting of receptor tyrosine kinase signaling.
    Int J Oncol. 2017 Jul 13. doi: 10.3892/ijo.2017.4073.
    PubMed     Text format     Abstract available
    
    
    
42. XU M, Qin S, Cao F, Ding S, et al
    MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer.
    Int J Oncol. 2017 Jul 12. doi: 10.3892/ijo.2017.4072.
    PubMed     Text format     Abstract available
    
    
    May 2017
43. KIM B, Kim YS, Ahn HM, Lee HJ, et al
    Peroxiredoxin 5 overexpression enhances tumorigenicity and correlates with poor prognosis in gastric cancer.
    Int J Oncol. 2017 May 19. doi: 10.3892/ijo.2017.4013.
    PubMed     Text format     Abstract available
    
    
    
44. DU Y, Jiang B, Song S, Pei G, et al
    Metadherin regulates actin cytoskeletal remodeling and enhances human gastric cancer metastasis via epithelial-mesenchymal transition.
    Int J Oncol. 2017 May 17. doi: 10.3892/ijo.2017.4002.
    PubMed     Text format     Abstract available
    
    
    
45. XIAO S, Zhou L
    Gastric cancer: Metabolic and metabolomics perspectives (Review).
    Int J Oncol. 2017 May 16. doi: 10.3892/ijo.2017.4000.
    PubMed     Text format     Abstract available
    
    
    
46. GE L, Li DS, Chen F, Feng JD, et al
    TAZ overexpression is associated with epithelial-mesenchymal transition in cisplatin-resistant gastric cancer cells.
    Int J Oncol. 2017 May 16. doi: 10.3892/ijo.2017.3998.
    PubMed     Text format     Abstract available
    
    
    
47. ZHUANG K, Zhang L, Zhang X, Tang H, et al
    Gastrin induces multidrug resistance via the degradation of p27Kip1 in the gastric carcinoma cell line SGC7901.
    Int J Oncol. 2017 May 4. doi: 10.3892/ijo.2017.3983.
    PubMed     Text format     Abstract available
    
    
    
48. ZENG XQ, Wang J, Chen SY
    Methylation modification in gastric cancer and approaches to targeted epigenetic therapy (Review).
    Int J Oncol. 2017 May 3. doi: 10.3892/ijo.2017.3981.
    PubMed     Text format     Abstract available
    
    
    
49. FUJIWARA Y, Okada K, Omori T, Sugimura K, et al
    Multiple therapeutic peptide vaccines for patients with advanced gastric cancer.
    Int J Oncol. 2017;50:1655-1662.
    PubMed     Text format     Abstract available
    
    
    April 2017
50. PAN Y, Shu X, Sun L, Yu L, et al
    miR196a5p modulates gastric cancer stem cell characteristics by targeting Smad4.
    Int J Oncol. 2017 Apr 19. doi: 10.3892/ijo.2017.3965.
    PubMed     Text format     Abstract available
    
    
    
51. WANG R, Song Y, Liu X, Wang Q, et al
    UBE2C induces EMT through Wnt/betacatenin and PI3K/Akt signaling pathways by regulating phosphorylation levels of Aurora-A.
    Int J Oncol. 2017;50:1116-1126.
    PubMed     Text format     Abstract available
    
    
    March 2017
52. HUANG T, Wang L, Liu D, Li P, et al
    FGF7/FGFR2 signal promotes invasion and migration in human gastric cancer through upregulation of thrombospondin-1.
    Int J Oncol. 2017 Mar 22. doi: 10.3892/ijo.2017.3927.
    PubMed     Text format     Abstract available
    
    
    
53. WANG C, Yang C, Ji J, Jiang J, et al
    Deubiquitinating enzyme USP20 is a positive regulator of Claspin and suppresses the malignant characteristics of gastric cancer cells.
    Int J Oncol. 2017 Mar 8. doi: 10.3892/ijo.2017.3904.
    PubMed     Text format     Abstract available
    
    
    
54. NASSER MI, Masood M, Wei W, Li X, et al
    Cordycepin induces apoptosis in SGC7901 cells through mitochondrial extrinsic phosphorylation of PI3K/Akt by generating ROS.
    Int J Oncol. 2017;50:911-919.
    PubMed     Text format     Abstract available
    
    
    February 2017
55. SHEN L, Luo Z, Wu J, Qiu L, et al
    Enhanced expression of alpha2,3-linked sialic acids promotes gastric cancer cell metastasis and correlates with poor prognosis.
    Int J Oncol. 2017 Feb 20. doi: 10.3892/ijo.2017.3882.
    PubMed     Text format     Abstract available
    
    
    
56. FUJIMOTO D, Goi T, Hirono Y
    Expression of ribophorine II is a promising prognostic factor in human gastric adenocarcinoma.
    Int J Oncol. 2017;50:448-456.
    PubMed     Text format     Abstract available
    
    
    December 2016
57. LEE JH, Kim SS, Lee HS, Hong S, et al
    Upregulation of SMAD4 by MZF1 inhibits migration of human gastric cancer cells.
    Int J Oncol. 2016 Dec 6. doi: 10.3892/ijo.2016.3793.
    PubMed     Text format     Abstract available
    
    
    November 2016
58. LI R, Yang HQ, Xi HL, Feng S, et al
    Inhibition of CDH17 gene expression via RNA interference reduces proliferation and apoptosis of human MKN28 gastric cancer cells.
    Int J Oncol. 2016 Nov 28. doi: 10.3892/ijo.2016.3783.
    PubMed     Text format     Abstract available
    
    
    October 2016
59. XU M, Zhou H, Zhang C, He J, et al
    ADAM17 promotes epithelial-mesenchymal transition via TGF-beta/Smad pathway in gastric carcinoma cells.
    Int J Oncol. 2016 Oct 21. doi: 10.3892/ijo.2016.3744.
    PubMed     Text format     Abstract available
    
    
    September 2016
60. HUANG T, Wang-Johanning F, Zhou F, Kallon H, et al
    MicroRNAs serve as a bridge between oxidative stress and gastric cancer (Review).
    Int J Oncol. 2016 Sep 9. doi: 10.3892/ijo.2016.3686.
    PubMed     Text format     Abstract available
    
    
    August 2016
61. TANG C, Jiang Y, Shao W, Shi W, et al
    Abnormal expression of FOSB correlates with tumor progression and poor survival in patients with gastric cancer.
    Int J Oncol. 2016 Aug 18. doi: 10.3892/ijo.2016.3661.
    PubMed     Text format     Abstract available
    
    
    
62. XIE P, Fujii I, Zhao J, Shinohara M, et al
    A novel polysaccharide derived from algae extract induces apoptosis and cell cycle arrest in human gastric carcinoma MKN45 cells via ROS/JNK signaling pathway.
    Int J Oncol. 2016 Aug 18. doi: 10.3892/ijo.2016.3658.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: